NASDAQ:SSRX - 3SBio Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$16.59 0.00 (0.00 %)
(As of 05/20/2018 03:46 PM ET)
Previous Close$16.59
Today's RangeN/A
52-Week Range$10.15 - $16.70
Average Volume149,084 shs
Market Capitalization$366.10 million
P/E RatioN/A
Dividend YieldN/A


3SBio logo3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on bio-pharmaceutical products. The Company recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin; and an in-licensed product, Iron Sucrose Supplement. The Company focuses on its research and development efforts on both novel and validated protein-based therapeutics for the treatment of diseases in the areas of nephrology, oncology, supportive cancer care, inflammation and infectious diseases, and other selected areas. In May 2013, the Company merged with Decade Sunshine Limited and Decade Sunshine Merger Sub.

Receive SSRX News and Ratings via Email

Sign-up to receive the latest news and ratings for SSRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

3SBio (NASDAQ:SSRX) Frequently Asked Questions

What is 3SBio's stock symbol?

3SBio trades on the NASDAQ under the ticker symbol "SSRX."

How were 3SBio's earnings last quarter?

3SBio Inc (NASDAQ:SSRX) announced its quarterly earnings data on Monday, March, 18th. The biotechnology company reported $0.12 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.14 by $0.02. The biotechnology company had revenue of $26.30 million for the quarter, compared to analysts' expectations of $25.63 million. View 3SBio's Earnings History.

Who are 3SBio's key executives?

3SBio's management team includes the folowing people:
  • Jing Lou, Executive Chairman of the Board, Chief Executive Officer (Age 54)
  • Bo Tan, Chief Financial Officer, Executive Vice President, Executive Director (Age 44)
  • Fei You, Director - Finance (Age 38)
  • Weihonghas Xiao, Chief Operating Officer (Age 48)
  • Dongmei Su, Senior Vice President, Executive Director (Age 46)
  • Zhenping Zhu MD. Ph.D., Chief Scientific Officer, President - Research & Development (Age 52)
  • Bin Huang, Vice President, Executive Director (Age 56)
  • Xin Ma, Vice President - Human Resources (Age 51)
  • Yongfu Chen, Vice President (Age 60)
  • Kevin Liu, Vice President (Age 47)

Has 3SBio been receiving favorable news coverage?

Media stories about SSRX stock have been trending somewhat positive on Sunday, Accern Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. 3SBio earned a media sentiment score of 0.18 on Accern's scale. They also assigned news stories about the biotechnology company an impact score of 45.27 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of 3SBio?

Shares of SSRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 3SBio's stock price today?

One share of SSRX stock can currently be purchased for approximately $16.59.

How big of a company is 3SBio?

3SBio has a market capitalization of $366.10 million.

How can I contact 3SBio?

3SBio's mailing address is No. 3 A1, Road 10 Shenyang Economy & Technology Development Zone, SHENYANG, LIA 110027, China. The biotechnology company can be reached via phone at +86-24-25811820.

MarketBeat Community Rating for 3SBio (SSRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  145
MarketBeat's community ratings are surveys of what our community members think about 3SBio and other stocks. Vote "Outperform" if you believe SSRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SSRX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

3SBio (NASDAQ:SSRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/ABuyBuy
Consensus Rating Score: N/AN/A3.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

3SBio (NASDAQ:SSRX) Consensus Price Target History

Price Target History for 3SBio (NASDAQ:SSRX)

3SBio (NASDAQ:SSRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/20/2017Goldman SachsUpgradeNeutral ➝ BuyLowView Rating Details
(Data available from 5/20/2016 forward)


3SBio (NASDAQ:SSRX) Earnings History and Estimates Chart

Earnings by Quarter for 3SBio (NASDAQ:SSRX)

3SBio (NASDAQ SSRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/18/2013Q4 2012$0.14$0.12$25.63 million$26.30 millionViewListenView Earnings Details
11/12/2012Q312$0.29$0.15$28.18 million$28.70 millionViewN/AView Earnings Details
8/14/2012Q2 2012$0.24$0.29ViewN/AView Earnings Details
5/13/2012Q1 2012$0.20$0.23ViewN/AView Earnings Details
3/8/2012Q4 2011$0.14$0.16ViewN/AView Earnings Details
11/10/2011Q3 2011$0.23$0.23ViewN/AView Earnings Details
8/15/2011Q2 2011$0.20$0.21ViewN/AView Earnings Details
5/11/2011Q1 2011$0.18$0.15ViewN/AView Earnings Details
3/15/2011Q4 2010$0.06$0.11ViewN/AView Earnings Details
11/15/2010Q3 2010$0.18$0.15ViewN/AView Earnings Details
8/17/2010Q2 2010$0.17$0.17ViewN/AView Earnings Details
5/16/2010Q1 2010$0.16$0.18ViewN/AView Earnings Details
2/11/2010Q4 2009$0.07$0.10ViewN/AView Earnings Details
11/12/2009Q3 2009$0.15$0.18ViewN/AView Earnings Details
8/11/2009Q2 2009$0.13$0.18ViewN/AView Earnings Details
5/19/2009Q1 2009$0.12$0.14ViewN/AView Earnings Details
3/11/2009Q4 2008$0.11$0.08ViewN/AView Earnings Details
11/10/2008Q3 2008$0.14$0.14ViewN/AView Earnings Details
8/12/2008Q2 2008$0.13$0.13ViewN/AView Earnings Details
5/14/2008Q1 2008$0.12$0.13ViewN/AView Earnings Details
2/20/2008Q4 2007$0.13$0.11ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


3SBio (NASDAQ:SSRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

3SBio (NASDAQ SSRX) Insider Trading and Institutional Ownership History

Insider Trading History for 3SBio (NASDAQ:SSRX)

3SBio (NASDAQ SSRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


3SBio (NASDAQ SSRX) News Headlines

Head-To-Head Comparison: Baxalta (BXLT) vs. 3SBio (SSRX)Head-To-Head Comparison: Baxalta (BXLT) vs. 3SBio (SSRX) - February 4 at 1:08 AM
Strongbridge Biopharma (SBBP) vs. 3SBio (SSRX) Head-To-Head ComparisonStrongbridge Biopharma (SBBP) vs. 3SBio (SSRX) Head-To-Head Comparison - January 6 at 7:14 PM
Contrasting 3SBio (SSRX) & KalVista Pharmaceuticals (KALV)Contrasting 3SBio (SSRX) & KalVista Pharmaceuticals (KALV) - December 26 at 11:54 PM
3SBio (SSRX) vs. Kamada (KMDA) Head-To-Head Analysis3SBio (SSRX) vs. Kamada (KMDA) Head-To-Head Analysis - December 26 at 6:18 PM
Head to Head Contrast: Kamada (KMDA) versus 3SBio (SSRX)Head to Head Contrast: Kamada (KMDA) versus 3SBio (SSRX) - December 26 at 5:24 PM
Financial Comparison: 3SBio (SSRX) vs. Its CompetitorsFinancial Comparison: 3SBio (SSRX) vs. Its Competitors - December 3 at 7:30 PM
Contrasting 3SBio (SSRX) & Its CompetitorsContrasting 3SBio (SSRX) & Its Competitors - November 23 at 3:12 PM
Financial Review: 3SBio (SSRX) versus Its RivalsFinancial Review: 3SBio (SSRX) versus Its Rivals - November 6 at 9:25 AM
3SBio (SSRX) and Its Rivals Head-To-Head Survey3SBio (SSRX) and Its Rivals Head-To-Head Survey - November 4 at 1:22 PM

SEC Filings


This page is loading this company's SEC Filings. Please wait...

Social Media


3SBio (NASDAQ:SSRX) Income Statement, Balance Sheet and Cash Flow Statement


3SBio (NASDAQ SSRX) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.